Clinical Trials
38 trialsVaccination of Patients With Renal Cell Cancer With Dendritic Cell Tumor Fusions and GM-CSF
Beth Israel Deaconess Medical Center
SLM + Axitinib for Clear Cell RCC
University of Iowa
MetroWilms
Centre Oscar Lambret
64Cu-GRIP B in Patients With Advanced Malignancies
University of California, San Francisco
A Safety And Efficacy Study Of HLA-G- Targeted CAR-T Cells IVS-3001 In Subjects With Previously Treated Advanced HLA-G-Positive Solid Tumors
M.D. Anderson Cancer Center
EBNK-ST-001
Essen Biotech
TAGNOT
Kidney Cancer Research Bureau
Autologous and Allogeneic Whole Cell Cancer Vaccine for Metastatic Tumors
Hadassah Medical Organization
PSMA Therapy and Immunotherapy in Kidney Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
HTL0039732 in Participants With Advanced Solid Tumours
Cancer Research UK
Talazoparib and Axitinib for People With Previously Treated Advanced Kidney Cancer
Memorial Sloan Kettering Cancer Center
Atezolizumab in Combination With Entinostat and Bevacizumab in Patients With Advanced Renal Cell Carcinoma
Indiana University
Safety and Preliminary Efficacy of Meldonium in Patients with Metastatic Renal Cell Carcinoma and Treatment-associated Fatigue
Kidney Cancer Research Bureau
Vorolanib Combined With Cadonilimab in the Treatment of Untreated Advanced RCC Patients
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Monoclonal Antibody Therapy in Treating Patients With Advanced Kidney Cancer
Ludwig Institute for Cancer Research
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
City of Hope Medical Center
A Study of Tremelimumab and IV Durvalumab Plus Poly-ICLC in Subjects With Biopsy-accessible Cancers
Ludwig Institute for Cancer Research
BNC105P in Combination With Everolimus/Following Everolimus For Progressive Metastatic Clear Cell Renal Cell Carcinoma
Hoosier Cancer Research Network
Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer
SCRI Development Innovations, LLC
Study of Durvalumab and Guadecitabine in Advanced Kidney Cancer
Big Ten Cancer Research Consortium
Safety and Efficacy of Tag-7 Gene-modified Vaccine in Locally Advanced or Metastatic Malignant Melanoma or Kidney Cancer
N.N. Petrov National Medical Research Center of Oncology
Combination of Cryosurgery and NK Immunotherapy for Advanced Kidney Cancer
Fuda Cancer Hospital, Guangzhou
KCM201
University of Oxford
Genistein in Treating Patients Undergoing External-Beam Radiation Therapy for Bone Metastases
Masonic Cancer Center, University of Minnesota
Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney Cancer
Masonic Cancer Center, University of Minnesota
5-AZ
University of Kansas Medical Center
QUASAR
Consorzio Oncotech
Phase I/II Trial of RAD001 Plus Nexavar in Patients With Kidney Cancer
The Methodist Hospital Research Institute
BEZ235 in Patients With Advanced Renal Cell Carcinoma (RCC)
Memorial Sloan Kettering Cancer Center
Study of Sorafenib and Palliative Radiotherapy in Kidney Cancer That Spreads to the Bone
University Health Network, Toronto
Efficacy and Safety of IRE for RMs
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Biological Therapy Plus Chemotherapy in Treating Patients With Metastatic or Recurrent Kidney Cancer
University of New Mexico
Chemotherapy in Treating Patients With Solid Tumors
Memorial Sloan Kettering Cancer Center
Interferon Alfa in Treating Patients With Advanced Kidney Cancer
Memorial Sloan Kettering Cancer Center
Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors
Duke University
Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
Jonsson Comprehensive Cancer Center
Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous Disease
Fred Hutchinson Cancer Center
Beclomethasone in Treating Patients With Graft-Versus-Host Disease of the Esophagus, Stomach, Small Intestine, or Colon
Fred Hutchinson Cancer Center